The microscope, known as Cellvizio, allows physicians to pinpoint cancerous and pre-cancerous tissue more effectively than before. The hospitals’ gastroenterologists Matt Reveille, MD, and John Groff, MD, are using the system to diagnose and treat early signs of esophageal, pancreatic and colon cancer.
More Articles on Gastroenterologists:
Gastroenterologist on the Move: Dr. Robert “Chip” Williams Joins Lumberton Children’s Clinic
Gastroenterologist on the Move: Dr. Ann Marie Stephenson
Gastroenterologist on the Move: Dr. Carlos Cardenas Named Interim CEO of TX’s Doctors Hospital at Renaissance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
